Q4 2024 Cryoport Inc Earnings Call Transcript

Mar 4, 2025 / 10:00 PM GMT

Release Date Price: €4.36 (-16.15%)

Transcript 10-K8-K

Key Points

Positve

CryoPort Inc (CYRX) achieved total annual revenues of $228.4 million in 2024, aligning with expectations.
The life sciences service business experienced double-digit year-over-year growth, with bio storage and bioservices showing significant expansion.
Revenue from commercial cell and gene therapies increased by 37% in Q4 and 20% for the full year.
CryoPort Inc (CYRX) supported a record number of 701 clinical trials, indicating potential commercial revenue opportunities.
The company improved its gross margin to 45.8% in Q4 2024, up from 40.6% in the same period last year.

Negative

2024 was a challenging year for the life sciences sector due to macroeconomic conditions and market dynamics.
The cryogenic systems market experienced a downturn, impacting the company's product segment.
There is uncertainty regarding the impact of tariffs on aluminum and stainless steel, which could affect costs.
The company has not provided specific guidance on the revenue contribution from the five new therapies approved in 2024.
The non-cell and gene therapy market is expected to grow only nominally or modestly, indicating limited expansion in this area.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CYRX.OQ - Cryoport Inc
Q4 2024 Cryoport Inc Earnings Call
Mar 04, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Cryoport's 4th quarter in full year 2024 earnings conference call. All participants will start in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call record immediate assistance, please press 0 for the operator. As a reminder, this call is being recorded. I'll now turn the call over to your host, Mr. Todd Frommer from KCSA Strategic Communications. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Before we begin today, I would like to remind everyone that

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.